Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herve Caspard

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Open Access Rheumatology : Research and Reviews|March 19, 2013
Incidence density of serious infection, opportunistic infection, and tuberculosis associated with biologic treatment in patients with rheumatoid arthritis - a systematic evaluation of the literatureTrung N Tran, Herve Caspard, Fabio Magrini
Clinical Therapeutics|December 7, 2005
The long-term course of low-density lipoprotein cholesterol after initiation of statin treatment: retrospective database analysis over 3 years in health maintenance organization enrolleesHerve Caspard, Arnold K Chan, Alexander M Walker
The Annals of Pharmacotherapy|December 1, 2005
Determinants of the differences in LDL-cholesterol after initiation of statin treatmentHerve Caspard, Arnold K Chan, Alexander M Walker
Clinical Therapeutics|December 7, 2005
Compliance with a statin treatment in a usual-care setting: retrospective database analysis over 3 years after treatment initiation in health maintenance organization enrollees with dyslipidemiaHerve Caspard, Arnold K Chan, Alexander M Walker
Vaccine|August 19, 2014
Efficacy of live attenuated influenza vaccine against influenza illness in children as a function of illness severityChristopher S Ambrose, Xionghua Wu, Herve Caspard, et al.
BMJ Open|July 19, 2017
Incidence of live-attenuated influenza vaccine administration beyond expiry date in children and adolescents aged 2-17 years in the UK: a population-based cohort studyHerve Caspard, Robert P Wise, Amy Steffey, et al.
Human Vaccines & Immunotherapeutics|January 12, 2016
A systematic review of the efficacy of live attenuated influenza vaccine upon revaccination of childrenHerve Caspard, Terho Heikkinen, Robert B Belshe, et al.
BMJ Open|December 12, 2018
Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research DatalinkHerve Caspard, Amy Steffey, Raburn M Mallory, et al.
Open Forum Infectious Diseases|August 31, 2017
Live-Attenuated Influenza Vaccine Effectiveness in Children From 2009 to 2015-2016: A Systematic Review and Meta-AnalysisHerve Caspard, Raburn M Mallory, Jing Yu, et al.
Vaccine|September 11, 2016
Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United StatesHerve Caspard, Kathleen L Coelingh, Raburn M Mallory, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Open Access Rheumatology : Research and Reviews|March 19, 2013
Incidence density of serious infection, opportunistic infection, and tuberculosis associated with biologic treatment in patients with rheumatoid arthritis - a systematic evaluation of the literatureTrung N Tran, Herve Caspard, Fabio Magrini
Clinical Therapeutics|December 7, 2005
The long-term course of low-density lipoprotein cholesterol after initiation of statin treatment: retrospective database analysis over 3 years in health maintenance organization enrolleesHerve Caspard, Arnold K Chan, Alexander M Walker
The Annals of Pharmacotherapy|December 1, 2005
Determinants of the differences in LDL-cholesterol after initiation of statin treatmentHerve Caspard, Arnold K Chan, Alexander M Walker
Clinical Therapeutics|December 7, 2005
Compliance with a statin treatment in a usual-care setting: retrospective database analysis over 3 years after treatment initiation in health maintenance organization enrollees with dyslipidemiaHerve Caspard, Arnold K Chan, Alexander M Walker
Vaccine|August 19, 2014
Efficacy of live attenuated influenza vaccine against influenza illness in children as a function of illness severityChristopher S Ambrose, Xionghua Wu, Herve Caspard, et al.
BMJ Open|July 19, 2017
Incidence of live-attenuated influenza vaccine administration beyond expiry date in children and adolescents aged 2-17 years in the UK: a population-based cohort studyHerve Caspard, Robert P Wise, Amy Steffey, et al.
Human Vaccines & Immunotherapeutics|January 12, 2016
A systematic review of the efficacy of live attenuated influenza vaccine upon revaccination of childrenHerve Caspard, Terho Heikkinen, Robert B Belshe, et al.
BMJ Open|December 12, 2018
Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research DatalinkHerve Caspard, Amy Steffey, Raburn M Mallory, et al.
Open Forum Infectious Diseases|August 31, 2017
Live-Attenuated Influenza Vaccine Effectiveness in Children From 2009 to 2015-2016: A Systematic Review and Meta-AnalysisHerve Caspard, Raburn M Mallory, Jing Yu, et al.
Vaccine|September 11, 2016
Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United StatesHerve Caspard, Kathleen L Coelingh, Raburn M Mallory, et al.
Pageof 3